Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For ...
WASHINGTON, Oct. 20, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced its intention to file a petition for a writ of certiorari in its HETLIOZ ® Abbreviated New Drug Application ...
Vanda Pharmaceuticals and the FDA have agreed to lay down their swords, squashing years of legal disputes with an agreement that will see regulatory action on much of Vanda’s grievances. The ...